Soluble CD8 and ICAM-1 in serum and CSF of MS patients treated with 6-methylprednisolone

Acta Neurologica Scandinavica
D FranciottaV Cosi

Abstract

We studied the effects of large doses of 6-methylprednisolone (6-MP) on serum and cerebrospinal fluid (CSF) soluble CD8 (sCD8) and intercellular adhesion molecule-1 (sICAM-1) levels in clinically active multiple sclerosis (MS) patients. Paired serum and CSF samples were from 16 patients with definite MS, treated with 6-MP (1 g daily for 6 d) during an active phase of the disease. sCD8 and sICAM-1 levels were determined with ELISA before and after the therapy. Before 6-MP treatment, sCD8 levels in CSF were higher in MS patients than in patients with noninflammatory neurological disease and in healthy controls; sICAM-1 levels in serum and in CSF were higher in MS patients than in the two control groups. Ten of the 16 patients showed clinical improvement at the end of the treatment. After the therapy, serum and CSF sCD8 levels increased, whereas serum and CSF sICAM-1 levels decreased. There was no correlation between clinical improvement and laboratory parameters. We evaluated sCD8 and sICAM-1 in serum samples from 10 patients 6 months after the 6-MP treatment, when the disease was clinically silent. Neither sCD8 nor sICAM-1 levels differed from those of the control groups. Our results suggest that high doses of 6-MP can influence...Continue Reading

References

Feb 1, 1992·Journal of Neuroscience Research·K RösslerH Lassmann
Jul 1, 1991·Clinical and Experimental Immunology·M TsujisakiA Yachi
Dec 15, 1990·International Journal of Cancer. Journal International Du Cancer·L GuariniP B Fisher
Jun 1, 1990·Clinical and Experimental Immunology·J A SymonsG W Duff
Nov 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·D R KaplanM L Tykocinski
Jun 1, 1988·Archives of Neurology·A Compston
Mar 1, 1983·Annals of Neurology·C M PoserW W Tourtellotte
Apr 1, 1995·Annals of Neurology·B Cannella, C S Raine
Apr 1, 1994·Clinical and Experimental Immunology·P H JakobsenB M Greenwood
Sep 1, 1996·Journal of Neurology, Neurosurgery, and Psychiatry·R A Hughes, B Sharrack

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Related Feeds

Adhesion Molecules in Health and Disease

Cell adhesion molecules are a subset of cell adhesion proteins located on the cell surface involved in binding with other cells or with the extracellular matrix in the process called cell adhesion. In essence, cell adhesion molecules help cells stick to each other and to their surroundings. Cell adhesion is a crucial component in maintaining tissue structure and function. Discover the latest research on adhesion molecule and their role in health and disease here.

Blood Brain Barrier Regulation in Health & Disease

The blood brain barrier is essential in regulating the movement of molecules and substances in and out of the brain. Disruption to the blood brain barrier and changes in permeability allow pathogens and inflammatory molecules to cross the barrier and may play a part in the pathogenesis of neurodegenerative disorders. Here is the latest research in this field.

Blood Brain Barrier Chips

The blood brain barrier (BBB) is comprised of endothelial cells that regulate the influx and outflux of plasma concentrations. Lab-on-a-chip devices allow scientists to model diseases and mechanisms such as the passage of therapeutic antibodies across the BBB. Discover the latest research on BBB chips here.

CSF & Lymphatic System

This feed focuses on Cerebral Spinal Fluid (CSF) and the lymphatic system. Discover the latest papers using imaging techniques to track CSF outflow into the lymphatic system in animal models.

Blood Brain Barrier

The blood brain barrier is a border that separates blood from cerebrospinal fluid. Discover the latest search on this highly selective semipermeable membrane here.